Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 10, Number 3, May 2011

Articles

Free Content Commentary (Research Highlights)
pp. 295-295(1)
Author: D. Skaper, Stephen

Favourites:
ADD

Structure and Function Relationship in Prolyl Oligopeptidase
pp. 297-305(9)
Authors: Van Elzen, Roos; Lambeir, Anne-Marie

Favourites:
ADD

Prolyl Oligopeptidase Structure and Dynamics
pp. 306-310(5)
Authors: Rea, Dean; Fulop, Vilmos

Favourites:
ADD

Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain
pp. 311-318(8)
Authors: Peltonen, Iida; T. Myohanen, Timo; T. Mannisto, Pekka

Favourites:
ADD

Hunting for Peptide Substrates of Prolyl Oligopeptidase: Classical Versus Non-Classical Bioactive Peptides
pp. 319-326(8)
Authors: Tenorio-Laranga, Jofre; T. Mannisto, Pekka; Arturo Garcia-Horsman, J.

Favourites:
ADD

Role of Prolyl Endopeptidase in Intracellular Transport and Protein Secretion
pp. 327-332(6)
Authors: Morawski, M.; Schulz, I.; Zeitschel, U.; Blosa, M.; Seeger, G.; Roßner, S.

Favourites:
ADD
Favourites:
ADD

Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
pp. 340-348(9)
Authors: Penttinen, Anne; Tenorio-Laranga, Jofre; Siikanen, Anssi; Morawski, Markus; Roßner, Steffen; Arturo Garcia-Horsman, J.

Favourites:
ADD

Interaction of Prolyl Oligopeptidase with α-Synuclein
pp. 349-354(6)
Author: Lambeir, Anne-Marie

Favourites:
ADD

PREPL, a Prolyl Endopeptidase-Like Enzyme by Name Only? Lessons from Patients
pp. 355-360(6)
Authors: Boonen, Kurt; Regal, Luc; Jaeken, Jaak; W.M. Creemers, John

Favourites:
ADD

Homocysteine in Neurological Disease: A Marker or a Cause?
pp. 361-369(9)
Authors: Khanna, Suruchi; Kapoor, Puneet; K. Pillai, K.; Vohora, Divya

Favourites:
ADD

Pharmacotherapy and Prevention of Vascular Dementia
pp. 370-390(21)
Authors: Moretti, A.; Gorini, A.; F. Villa, R.

Favourites:
ADD

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
pp. 391-403(13)
Authors: A. Frankola, Kathryn; H. Greig, Nigel; Luo, Weiming; Tweedie, David

Favourites:
ADD

Hemichannels in the Neurovascular Unit and White Matter Under Normal and Inflamed Conditions
pp. 404-414(11)
Authors: A. Orellana, Juan; F. Figueroa, Xavier; A. Sanchez, Helmuth; Contreras-Duarte, Susana; Velarde, Victoria; C. Saez, Juan

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more